CA1048933A - Compose pharmaceutique pour le traitement de l'hyperuricemie - Google Patents

Compose pharmaceutique pour le traitement de l'hyperuricemie

Info

Publication number
CA1048933A
CA1048933A CA76253650A CA253650A CA1048933A CA 1048933 A CA1048933 A CA 1048933A CA 76253650 A CA76253650 A CA 76253650A CA 253650 A CA253650 A CA 253650A CA 1048933 A CA1048933 A CA 1048933A
Authority
CA
Canada
Prior art keywords
allopurinol
benzbromaron
preparation according
dosage unit
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA76253650A
Other languages
English (en)
Inventor
Ekkehard Scheiffele
Guido Weickgenannt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henning Berlin GmbH Chemie- und Pharmawerk
Original Assignee
Henning Berlin GmbH Chemie- und Pharmawerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henning Berlin GmbH Chemie- und Pharmawerk filed Critical Henning Berlin GmbH Chemie- und Pharmawerk
Application granted granted Critical
Publication of CA1048933A publication Critical patent/CA1048933A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA76253650A 1975-12-10 1976-05-28 Compose pharmaceutique pour le traitement de l'hyperuricemie Expired CA1048933A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752555609 DE2555609A1 (de) 1975-12-10 1975-12-10 Pharmazeutisches praeparat zur therapie der hyperurikaemie

Publications (1)

Publication Number Publication Date
CA1048933A true CA1048933A (fr) 1979-02-20

Family

ID=5964014

Family Applications (1)

Application Number Title Priority Date Filing Date
CA76253650A Expired CA1048933A (fr) 1975-12-10 1976-05-28 Compose pharmaceutique pour le traitement de l'hyperuricemie

Country Status (8)

Country Link
AU (1) AU505476B2 (fr)
BE (1) BE842389A (fr)
CA (1) CA1048933A (fr)
DE (1) DE2555609A1 (fr)
FR (1) FR2334362A1 (fr)
GB (1) GB1493237A (fr)
NL (1) NL7605531A (fr)
ZA (1) ZA763081B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005046724A1 (fr) 2003-11-14 2005-05-26 Human Cell Systems, Inc. Remede curatif ou preventif des troubles vasculaires et de l'hypertension et son procede de criblage
WO2005082840A1 (fr) 2004-03-01 2005-09-09 Japan Science And Technology Agency Procédé pour l'allylation de n-acylhydrazones
JP2008506785A (ja) * 2004-07-21 2008-03-06 フロリダ大学 リサーチファウンデーション インコーポレイティッド インスリン抵抗性の治療及び予防のための組成物及び方法
WO2012048058A2 (fr) * 2010-10-06 2012-04-12 J-Pharma Co., Ltd. Développement de puissants inhibiteurs des transporteurs d'urate : composés conçus pour leur action uricosurique
CN103242272B (zh) * 2013-05-22 2016-01-27 合肥医工医药有限公司 一种制备苯溴马隆的方法

Also Published As

Publication number Publication date
AU1541376A (en) 1978-01-05
NL7605531A (nl) 1977-06-14
FR2334362B1 (fr) 1979-08-24
DE2555609A1 (de) 1977-06-30
FR2334362A1 (fr) 1977-07-08
AU505476B2 (en) 1979-11-22
ZA763081B (en) 1977-04-27
GB1493237A (en) 1977-11-30
BE842389A (fr) 1976-09-16

Similar Documents

Publication Publication Date Title
RU2140266C1 (ru) Фармацевтическая композиция с регулируемым выделением на основе одной или нескольких фармацевтически приемлемых солей гамма-гидроксимасляной кислоты и способ ее получения
AU597471B2 (en) Stabilized ace inhibitor compositions
US5206264A (en) Use of disulfiram to prevent cardiovascular damage
CA2355814C (fr) Composition pharmaceutique pour utilisation ophthalmologique
SHILS Experimental human magnesium depletion: I. Clinical observations and blood chemistry alterations
Sorenson et al. Treatment of rheumatoid and degenerative diseases with copper complexes: a review with emphasis on copper-salicylate
US6191153B1 (en) Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity
JPH11514629A (ja) 安定な甲状腺ホルモン含有薬剤
CA1048933A (fr) Compose pharmaceutique pour le traitement de l'hyperuricemie
US3196078A (en) Process for combating retinits pigmentosa
Fine et al. Malabsorption of frusemide caused by phenytoin.
US4914095A (en) Use of imidazobenzodiazepines for psychotic disorders
Fleetham et al. Silo-filler's disease.
KR101086040B1 (ko) 간섬유화 및 간경화 치료 효과를 갖는 아시아트산 유도체
HENCH Gold salts for rheumatoid arthritis
US5192806A (en) Method of preventing penile tissue degenerative change
Jacobsen et al. 4-Methylpyrazole–present status
Clarke et al. Confusion and paranoia associated with oral tocainide
US3894153A (en) Method of medical treatment of asthma
Marley Non-thrombocytopenic Purpura after Chlorpromazine
CN115671118B (zh) 一种褐藻寡糖的用途
US3627886A (en) Methods of solubilizing coumermycin employing urea, dimethylacetamide or mixtures thereof
CN110664799B (zh) 用于治疗脑缺血的药物组合物及其应用
Borreli et al. The co-operative action of hyaluronidase and urokinase on the isoproterenol-induced myocardial infarction in rats
US4105794A (en) Process of mitigating cholelithiasis